#biosimilars — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #biosimilars, aggregated by home.social.
-
Alvotech Reports Positive PK Results for AVT80
Alvotech has announced top-line results from a pivotal pharmacokinetic study of AVT80, a proposed biosimilar to Entyvio (vedolizumab). The randomized, double-blind, 3-arm study assessed PK similarity, safety, and immunogenicity in healthy adults after a single 108 mg/0.68 mL subcutaneous injection. The data supports the development of the candidate for patients worldwide.
-
Alvotech Secures Global Settlement for Aflibercept Biosimilar
Alvotech reached a settlement to market its biosimilar globally. Entry starts Jan 1, 2026, in the UK and Canada. The EEA and other regions follow May 1, 2026. Japan allows full indications by Nov 1, 2026. Combined with a US Q4 2026 license, the company secures worldwide rights to supply partners, subject to regulatory approval.
-
AbbVie's tight grip on Humira market raises concerns about biosimilars—As biotech recovers, venture firms’ preferences appear to shift — Boehringer, Zealand heat up MASH race with strong phase II data—http://bit.ly/w28kSd #abbvie #humira #biosimilars #funding #mash #nash #boehringeringelheim #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
AstraZeneca to pay Pfizer $107.5M in damages in Tagrisso patent tussle—FDA approves two biosimilars to blockbuster eye drug Eylea —Why AlphaFold 3 is stirring up so much buzz in pharma --http://bit.ly/w28kSd #astrazeneca #pfizer #patents #legal #biosimilars #fda #eylea #ai #googledeepmind #drugdevelopment #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
A group of managed care organizations is examining the value of real world data from Europe and the U.S. to help FDA review alternative biologic drugs.
https://sciencebusiness.technewslit.com/?p=45310
#News #Press #Science #Business #Biologics #Biosimilars #Pharmaceuticals #FDA #Regulations #Grant #RealWorldData #HealthRecords #InsuranceClaims #ManagedCare #DataScience
-
Humira #biosimilars set the stage for long-awaited 2023 US launches - Pharmaceutical Technology
https://www.pharmaceutical-technology.com/features/humira-biosimilars-set-the-stage-for-long-awaited-2023-us-launches/ “There are seven FDA-approved Humira biosimilars, of which Amgen’s Amjevita will be launched in January. Others are made by big pharma giants like Boehringer Ingelheim, Novartis, or Pfizer, which has raised the expectations for a competitive market. “ #pharma